Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study

Fig. 1

Visual predictive check of the final in-house model for LPV. Open circles represent the observed plasma concentrations; black solid and dashed lines represent the median and PI90% of the observed data, respectively; shaded surfaces represent the model-predicted 90% confidence interval of the simulated median and PI90%. Note: One concentration with time after dose beyond 40 h is not displayed

Back to article page